Zinc Oxide

CHEMBL3988900 Phase 4 Aprovado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
81.4 g/mol
LogP
Phase
4

Zinc oxide is an inorganic compound with multiple pharmaceutical applications including broad-spectrum UV radiation absorption (UVA and UVB) for use as a physical sunscreen, and topical zinc-mediated wound healing and anti-inflammatory effects for treating diaper rash, minor skin irritations, and dermatitis. It is used as an active sunscreen ingredient and a protective skin barrier agent in various dermatological preparations. In ophthalmology, zinc oxide is a component of ocular zinc supplements investigated for slowing age-related macular degeneration progression.

Peso Molecular

81,4000 g/mol

TPSA

1,00 Ų

Áreas Terapêuticas

Mecanismo de Ação

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mecanismo

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Estrutura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

[O-2].[Zn+2]

InChI

InChI=1S/O.Zn/q-2;+2

Molecular Formula

OZn

HBD / HBA

- / 1

Ligações Rotacionáveis

0

Átomos Pesados

2

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

Zinc oxide is an inorganic compound with multiple pharmaceutical applications including broad-spectrum UV radiation absorption (UVA and UVB) for use as a physical sunscreen, and topical zinc-mediated wound healing and anti-inflammatory effects for treating diaper rash, minor skin irritations, and dermatitis. It is used as an active sunscreen ingredient and a protective skin barrier agent in various dermatological preparations. In ophthalmology, zinc oxide is a component of ocular zinc supplements investigated for slowing age-related macular degeneration progression.

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Yes, Zinc Oxide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3988900. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 3007857. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.